Chi Su is a graduate student in Pharmacology Program. He received medical education at the University of South China and got his practice license in 2016. Then he came to Rutgers University and got a master’s degree in Biomedical Sciences on May 2020.
Chi’s research is focused on developing novel compounds of mitochondrial uncouplers to treat metabolic disorders (Type 2 diabetes, non-alcoholic steatosis hepatitis) and cancer in vitro and in mouse models.